Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, providing a decentralized, automated, and efficient manufacturing platform for...
TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits....
Dyno Therapeutics, Inc, a techbio company pioneering applications of artificial intelligence to engineer AAV capsids that can expand the potential of genetic medicine, announced...
Athersys, Inc , a cell therapy and regenerative medicine company developing MultiStem for critical care indications, announced that the United States Patent and Trademark Office...
Porton Advanced Solutions (Porton Advanced) announced the completion of its Series B financing round with over US$80Million. Current round of financing was led by...
